Based in South San Francisco, Hyperion Therapeutics is a biopharmaceutical company that focuses on creating therapies for rare diseases that affect orphan or underserved patient populations. Their treatments address urea cycle disorders, hepatic encephalopathy, and other related diseases, with the goal of providing timely and affordable patient access. As a commercial-stage company, Hyperion is committed to advancing science and developing treatments for orphan and hepatic diseases.